Structural basis of ferroportin inhibition by minihepcidin PR73
PLOS Biology · 2023
DOI: 10.1371/journal.pbio.3001936 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Biology, 2023. Verfasst von Azaan Saalim Wilbon und 4 weiteren Autor:innen. Beteiligte Einrichtung: Verna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, Texas, United States of America. Hauptthemen laut MEDLINE: Hemochromatosis, Cation Transport Proteins. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NHLBI NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Ferroportin (Fpn) is the only known iron exporter in humans and is essential for maintaining iron homeostasis. Fpn activity is suppressed by hepcidin, an endogenous peptide hormone, which inhibits iron export and promotes endocytosis of Fpn. Hepcidin deficiency leads to hemochromatosis and iron-loading anemia. Previous studies have shown that small peptides that mimic the first few residues of hepcidin, i.e., minihepcidins, are more potent than hepcidin. However, the mechanism of enhanced inhibition by minihepcidins remains unclear. Here, we report the structure of human ferroportin in complex with a minihepcidin, PR73 that mimics the first 9 residues of hepcidin, at 2.7 Å overall resolution. The structure reveals novel interactions that were not present between Fpn and hepcidin. We validate PR73-Fpn interactions through binding and transport assays. These results provide insights into how minihepcidins increase inhibition potency and will guide future development of Fpn inhibitors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Verna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, Texas, United States of America.
- Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, United States of America.
ORCID-Profile: Ming Zhou, Yaping Pan
Förderung
- NIDDK NIH HHS
- NHLBI NIH HHS
- NIGMS NIH HHS
- National Heart, Lung, and Blood Institute
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Institute of General Medical Sciences
- Cancer Prevention and Research Institute of Texas
- Simons Foundation
Zitieren
APA
Wilbon, A. S., Shen, J., Ruchala, P., Zhou, M., & Pan, Y. (2023). Structural basis of ferroportin inhibition by minihepcidin PR73. PLOS Biology. https://doi.org/10.1371/journal.pbio.3001936
Vancouver
Wilbon AS, Shen J, Ruchala P, Zhou M, Pan Y. Structural basis of ferroportin inhibition by minihepcidin PR73. PLOS Biology. 2023. doi:10.1371/journal.pbio.3001936
BibTeX
@article{Wilbon2023,
author = {Wilbon, Azaan Saalim and Shen, Jiemin and Ruchala, Piotr and Zhou, Ming and Pan, Yaping},
title = {Structural basis of ferroportin inhibition by minihepcidin PR73},
journal = {PLOS Biology},
year = {2023},
doi = {10.1371/journal.pbio.3001936}
}
EUVIMED